Document Detail

Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries.
MedLine Citation:
PMID:  22717928     Owner:  NLM     Status:  In-Data-Review    
Aims: This study evaluated vascular compatibility of the novel platinum chromium alloy Element™ stent platform delivering abluminal everolimus from a poly-lactide-co-glycolide bioabsorbable polymer (SYNERGY™ stent), currently undergoing clinical trial, compared with the PROMUS® (XIENCE V) and bare metal and polymer-only Element™ stents. Methods and results: Stents (n=161) were implanted one per coronary artery in 72 swine at a stent-to-artery ratio of 1.1:1. Similar numbers of each device group were explanted at each of 30, 90, 180, and 360 days (except no PROMUS® (XIENCE V) stent at 360 days) for pathological analysis. There was no stent thrombosis, myocardial infarction, or strut fractures in any group. Vascular response was similar between the SYNERGY™ and PROMUS® (XIENCE V) stents, with no thrombi and complete endothelialisation on both scanning electron microscopy and histology at 30, 90 and 180 days. There were no significant differences for the morphologic parameters of luminal thrombus, endothelial cell coverage, strut tissue coverage, inflammation, internal elastic lamina (IEL) disruption, external elastic lamina (EEL) disruption and medial smooth muscle cell loss across device groups or between time points, but there was mild but greater (p<0.0001) para-strut fibrin at 30 days for both drug-eluting stents (DES) compared with the bare and polymer-only controls; this difference completely dissipated by 90 days. Inflammation was predominantly minimal to mild for all device types. No morphometric parameters, including intimal thickness, stent profile-based area stenosis, and EEL area were significantly different when comparing the SYNERGY stent with the bare metal Element™ and polymer-only Element™ control stents at 90, 180 and 360 days. Conclusions: In this non-injured porcine coronary artery model, the bioabsorbable polymer SYNERGY™ stent demonstrated vascular compatibility equivalent to the PROMUS® (XIENCE V) stent and to the bare metal and polymer-only Element™ stents.
Gregory J Wilson; Barbara A Huibregtse; Douglas E Pennington; Keith D Dawkins
Related Documents :
22481838 - Unilateral absence of a pulmonary artery: a rare disorder with variable presentation.
11565728 - Multicenter experience with the remote access perfusion (rap) catheter.
3631598 - Bunegin-albin catheter improves air retrieval and resuscitation from lethal venous air ...
22788888 - Early histological changes in the porcine aortic media after thoracic stent-graft impla...
6725508 - Aromatization by splanchnic tissue in men.
15791738 - Chemical meningitis after cerebral aneurysm treatment using two second-generation aneur...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  8     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  250-7     Citation Subset:  IM    
Division of Pathology, Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adjusting a polymer formulation for an optimal bioresorbable stent: a 6-month follow-up study.
Next Document:  Elevated liver enzymes, anaemia and osteopaenia in a young woman.